A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2009
11/18/2009	EP1317548B1 Transglutaminase gene products
11/18/2009	EP1292671B1 Method for obtaining characterised muscle-derived cell populations and uses
11/18/2009	EP0914422B1 Mammalian genes involved in viral infection
11/18/2009	CN101583381A HSV-1 and HSV-2 vaccines and methods of use thereof
11/18/2009	CN101580850A Specificity expression marker gene on telomerase masculine tumor cell, slow virus for curing gene and application thereof
11/18/2009	CN101580849A Dna-transfection system for generation of infectious influenza virus
11/18/2009	CN101580845A Vector capable of inducing cancer cell-apoptosis and use thereof
11/18/2009	CN101580833A SiRNA for inhibiting rat Atpase a3 gene expression, recombinant slow virus and application in medicament for treating bone absorption abnormal diseases
11/18/2009	CN101580542A Application of mycobacterium tuberculosis adhesion HBHA in diagnosing and treating tuberculosis
11/18/2009	CN101580540A Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof
11/18/2009	CN101579529A Oligonucleotide compositions and method for treating disease including inflammatory conditions
11/18/2009	CN101579528A HIV composite multi-epitope DNA vaccine and application thereof
11/18/2009	CN101579527A HLA Specific human cytomegalovirus Multi-epitope adenovirus DNA Vaccine of Chinese population
11/18/2009	CN101579362A Compositions and method for tumor-target delivery of effect molecules
11/18/2009	CN101579351A Application of ACL on sieving drugs for preventing obesity-related metabolic disturbance diseases
11/18/2009	CN101579315A Immunoliposome based on endostatin gene, preparation method and application thereof
11/17/2009	US7619080 Oligonucleotides of a chicken leukemia inhibitory factor (LIF) gene
11/17/2009	US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009	US7618941 Treating degenerative joint disorders with tribonectins
11/17/2009	US7618787 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor
11/17/2009	US7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
11/17/2009	US7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
11/17/2009	US7618637 Therapeutic mixture comprising chaperone protein for use in treatment and prevention of autoimmune, infectious and allergic disorders
11/17/2009	US7618636 Sequences from the bacterium Neisseria meningitidis.
11/17/2009	US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618623 Hybrid adeno-retroviral vector for the transfection of cells
11/17/2009	CA2318536C Method of and compositions for immunization with the pseudomonas v antigen
11/17/2009	CA2291754C Smad-interacting polypeptides and their use
11/17/2009	CA2258483C Biocompatible devices with foam scaffolds
11/17/2009	CA2206515C Identification of genes which allow a microorganism to adapt to a particular environment
11/17/2009	CA2166079C Chemically modified oligonucleotide for site-directed mutagenesis
11/17/2009	CA2157577C Growth differentiation factor-8
11/17/2009	CA2116327C Method and compositions for cellular reprogramming
11/14/2009	CA2665958A1 High affinity binding site of hgfr and methods for identification of antagonists thereof
11/12/2009	WO2009137801A2 Inhibitory rnas that regulate hematopoietic cells
11/12/2009	WO2009137795A2 Methods for treating endoplasmic reticulum (er) stress disorders
11/12/2009	WO2009137689A2 Delivery of nucleic acid complexes from particles
11/12/2009	WO2009137465A2 Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure
11/12/2009	WO2009137006A2 Directed evolution and in vivo panning of virus vectors
11/12/2009	WO2009136501A1 Method and kit for detection of cancer, and therapeutic agent for cancer
11/12/2009	WO2009135335A1 A method for inactivating mitogen activated protein kinase
11/12/2009	WO2009135295A1 Phage lambda display constructs
11/12/2009	WO2009111088A3 Antitumor immunization by liposomal delivery of vaccine to the spleen
11/12/2009	WO2009104889A3 Trem-2 gene and protein as inhibitors of expression of ga733-2, transgenic animals comprising the same, and uses thereof
11/12/2009	US20090281170 Polynucleotide therapy
11/12/2009	US20090281165 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/12/2009	US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009	US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009	US20090280164 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/12/2009	US20090280144 Recombinant newcastle disease virus RNA expression systems and vaccines
11/12/2009	US20090280088 Method of controlling hair shape
11/12/2009	CA2761105A1 Phage lambda display constructs
11/12/2009	CA2723372A1 Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure
11/12/2009	CA2723192A1 Delivery of nucleic acid complexes from particles
11/11/2009	EP2116259A1 TACI-immunoglobulin fusion proteins
11/11/2009	EP2116240A1 Augmented cognitive training with HT0712
11/11/2009	EP2115164A2 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
11/11/2009	EP2114987A1 Foxp3 peptide vaccine
11/11/2009	EP2114460A2 Methods and compositions for the disruption of biofilms
11/11/2009	EP2114433A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
11/11/2009	EP2114422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
11/11/2009	EP2114167A1 Non-human animals with human-glial chimeric brains
11/11/2009	EP2114153A2 Treatment and prevention of neurodegenerative diseases using gene therapy
11/11/2009	EP2114130A2 Animal model for adhd
11/11/2009	EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/11/2009	EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same
11/11/2009	EP1278874B1 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/11/2009	CN101578114A Radioimmunotherapy and imaging of tumor cells that express viral antigens
11/11/2009	CN101575646A Application of syncytin gene in malignancy in blood system
11/11/2009	CN101575616A Bird flu, Marek's disease dual live vaccine rMDV-HA viral strain and construction method thereof
11/11/2009	CN101575615A Construction of recombined lentivirus vector aiming at PKC gamma gene RNA interference and application thereof
11/11/2009	CN101575608A Recombinant combined DNA vaccine aiming to avian influenza virus
11/11/2009	CN101575607A Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression
11/11/2009	CN101575604A Slow virus vector, preparation thereof and application thereof
11/11/2009	CN101575602A siRNA sequence for inhibiting human BFGF gene expression amplification and expression carrier and application thereof
11/11/2009	CN101574528A siRNA and expression plasmid for inhibiting human hRAD21 gene expression and pharmacy application thereof
11/11/2009	CN101574527A Liver-targeting intelligent nano-micelle prodrug system and preparation thereof
11/11/2009	CN100558903C Photochemical internalization for delivery of molecules into the cytosol
11/11/2009	CN100558745C Specific inhibition of allograft rejection
11/11/2009	CN100558740C Use of antisense oligonucleotides to inhibit the expression of Akt-1
11/11/2009	CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009	CN100558396C A composition for wound healing and use thereof
11/10/2009	US7615627 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy
11/10/2009	US7615626 The agent consisting of targeting nucleic acid sequence that is complementary to a nucleic acid sequence in the undifferentiated mammalian cells and one or more other nucleic acid sequences not complementary to the nucleic acid sequence in the undifferentiated mammalian cells; osteoporosis treatment
11/10/2009	US7615623 BAG proteins and nucleic acid molecules encoding them
11/10/2009	US7615622 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor VIII
11/10/2009	US7615612 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders
11/10/2009	US7615610 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/10/2009	US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009	US7615539 Nucleic acid-lipophilic conjugates
11/10/2009	US7615538 Method for therapy of rheumatoid arthritis
11/10/2009	US7615537 Methods for treating blood coagulation disorders
11/10/2009	US7615383 Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies
11/10/2009	US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
11/10/2009	US7615341 Using allelic mutation on human chromosome 8 as diagnostic indicator of degenerative joint disease
11/10/2009	US7615212 Administering to the joint having systemic onset juvenile idiopathic arthritis an active agent that will reduce the bioavailability of interleukin-1 beta (IL-1 beta) by modifying the transcription, translation or gene expression or by blocking the IL-1 beta recepter;antiinflammatory agent; antipyretics
11/10/2009	US7615210 Treatment of endometriosis
11/10/2009	CA2479476C Compositions and methods for the treatment of tumor
11/10/2009	CA2251027C Defective viral vaccine particles obtained in vivo or ex vivo

1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 870